David Mountcastle - Jul 15, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: EVP & Chief Financial Officer
Signature: /s/ Thomas Bartrum, as attorney-in fact
Stock symbol: PRVA
Transactions as of: Jul 15, 2022
Transactions value $: -$861,686
Form type: 4
Date filed: 7/19/2022, 04:53 PM
Previous filing: Jul 8, 2022
Next filing: Jul 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, par value $0.01 per share	Options Exercise	$6.86K	+3.43K	+3.7%	$2.00^*	96.1K	Jul 15, 2022	Direct
transaction	PRVA	Common Stock, par value $0.01 per share	Sale	-$120K	-3.43K	-3.57%	$35.00	92.7K	Jul 15, 2022	Direct	F1, F2
transaction	PRVA	Common Stock, par value $0.01 per share	Options Exercise	$104K	+51.8K	+55.86%	$2.00^*	144K	Jul 18, 2022	Direct
transaction	PRVA	Common Stock, par value $0.01 per share	Sale	-$851K	-25K	-17.31%	$34.06	119K	Jul 18, 2022	Direct	F1, F3
transaction	PRVA	Common Stock, par value $0.01 per share	Sale	-$875	-25	-0.02%	$35.00	119K	Jul 18, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-3.43K	-3.54%	$0.00	93.6K	Jul 15, 2022	Common Stock	3.43K	$2.00	Direct	F4, F5
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-51.8K	-55.31%	$0.00	41.8K	Jul 18, 2022	Common Stock	51.8K	$2.00	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.015 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.81 to $34.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4	Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 79,753 of the stock options are fully vested and exercisable. 17,244 of the stock options will vest on October 29, 2022.
F5	These stock options were previously reported on the Form 3 filed by the Reporting Person with an Expiration Date that was incorrectly stated as 03/31/2029.